94 related articles for article (PubMed ID: 1736037)
1. ACAT activity in freshly isolated human mononuclear cell homogenates from hyperlipidemic subjects.
Dallongeville J; Davignon J; Lussier-Cacan S
Metabolism; 1992 Feb; 41(2):154-9. PubMed ID: 1736037
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new single-nucleotide polymorphism in the Acyl-CoA:cholesterol acyltransferase-2 gene on plasma lipids and apolipoproteins in patients with hyperlipidemia.
Katsuren K; Fukuyama S; Takata K; Ohta T
J Atheroscler Thromb; 2003; 10(1):32-6. PubMed ID: 12621162
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias.
Huff MW; Evans AJ; Sawyez CG; Wolfe BM; Nestel PJ
Arterioscler Thromb; 1991; 11(2):221-33. PubMed ID: 1998641
[TBL] [Abstract][Full Text] [Related]
4. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
5. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects.
Marcoux C; Tremblay M; Fredenrich A; Jacques H; Krimbou L; Nakajima K; Davignon J; Cohn JS
Atherosclerosis; 1998 Jul; 139(1):161-71. PubMed ID: 9699904
[TBL] [Abstract][Full Text] [Related]
6. The influence of the acyl-CoA:cholesterol acyltransferase-1 gene (-77G-->A) polymorphisms on plasma lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects.
Ohta T; Takata K; Katsuren K; Fukuyama S
Biochim Biophys Acta; 2004 Jun; 1682(1-3):56-62. PubMed ID: 15158756
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma cholesterol levels and cholesterol esterification in isolated human mononuclear cells.
Dallongeville J; Davignon J; Lussier-Cacan S
Life Sci; 1990; 47(25):2351-7. PubMed ID: 2263163
[TBL] [Abstract][Full Text] [Related]
9. In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Decreased enzyme catalytic efficiency in familial hypercholesterolemia.
Stacpoole PW; Bridge DM; Alvarez IM; Goldberg RB; Harwood HJ
J Clin Invest; 1987 Nov; 80(5):1401-8. PubMed ID: 2824560
[TBL] [Abstract][Full Text] [Related]
10. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
Vaziri ND; Liang K
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma.
Fielding PE; Fielding CJ; Havel RJ; Kane JP; Tun P
J Clin Invest; 1983 Mar; 71(3):449-60. PubMed ID: 6826717
[TBL] [Abstract][Full Text] [Related]
12. Suppression by diets rich in fish oil of very low density lipoprotein production in man.
Nestel PJ; Connor WE; Reardon MF; Connor S; Wong S; Boston R
J Clin Invest; 1984 Jul; 74(1):82-9. PubMed ID: 6736254
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
[TBL] [Abstract][Full Text] [Related]
14. Acyl-CoA binding protein (ACBP) regulates acyl-CoA:cholesterol acyltransferase (ACAT) in human mononuclear phagocytes.
Kerkhoff C; Beuck M; Threige-Rasmussen J; Spener F; Knudsen J; Schmitz G
Biochim Biophys Acta; 1997 Jun; 1346(2):163-72. PubMed ID: 9219899
[TBL] [Abstract][Full Text] [Related]
15. Regulation of plasma lecithin:cholesterol acyltransferase in man. I. Increased activity in primary hypertriglyceridemia.
Rose HG; Juliano J
J Lab Clin Med; 1976 Jul; 88(1):29-43. PubMed ID: 180216
[TBL] [Abstract][Full Text] [Related]
16. Structure of the human acyl-CoA:cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia.
Katsuren K; Tamura T; Arashiro R; Takata K; Matsuura T; Niikawa N; Ohta T
Biochim Biophys Acta; 2001 Apr; 1531(3):230-40. PubMed ID: 11325614
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
Vessby B; Hedstrand H; Olsson U
Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
[TBL] [Abstract][Full Text] [Related]
18. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.
Simons LA; Hickie JB; Balasubramaniam S
Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229
[TBL] [Abstract][Full Text] [Related]
19. Acyl-coenzyme A:cholesterol acyltransferase in human liver. In vitro detection and some characteristics of the enzyme.
Erickson SK; Cooper AD
Metabolism; 1980 Oct; 29(10):991-6. PubMed ID: 7421586
[TBL] [Abstract][Full Text] [Related]
20. Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients. A placebo-controlled trial.
Harris WS; Dujovne CA; Zucker M; Johnson B
Ann Intern Med; 1988 Sep; 109(6):465-70. PubMed ID: 3166357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
